BiotechTube

tramadol hydrochloride + acetaminophen

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Surgery, Oral

Conditions

Surgery, Oral, Pain, Postoperative

Trial Timeline

Nov 1, 2002 → Feb 1, 2003

NCT ID
NCT00236483

About tramadol hydrochloride + acetaminophen

tramadol hydrochloride + acetaminophen is a approved stage product being developed by Johnson & Johnson for Surgery, Oral. The current trial status is completed. This product is registered under clinical trial identifier NCT00236483. Target conditions include Surgery, Oral, Pain, Postoperative.

What happened to similar drugs?

19 of 20 similar drugs in Surgery, Oral were approved

Approved (19) Terminated (0) Active (1)
✅Popliteal nerve block including liposomal bupivacaine + Adductor canal nerve block including liposomal bupivacaine + Continuous popliteal nerve block with normal saline + Popliteal nerve block with exclusively unencapsulated bupivacaine + Adductor canal nerve block with exclusively unencapsulated bupivacaine + Continuous popliteal nerve block with unencapsulated bupivacainePacira BiosciencesApproved
✅EsomeprazoleAstraZenecaApproved
✅Sugammadex + Neostigmine + Glycopyrrolate + RocuroniumMerckApproved
✅Rocuronium + RocuroniumMerckApproved
✅SugammadexMerckApproved
✅etoricoxib 120 mgMerckApproved
✅Sugammadex + PlaceboMerckApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00766675ApprovedCompleted
NCT00236483ApprovedCompleted

Competing Products

20 competing products in Surgery, Oral

See all competitors
ProductCompanyStageHype Score
Ilofotase alfa + PlaceboAM-PharmaPhase 2
25
Popliteal nerve block including liposomal bupivacaine + Adductor canal nerve block including liposomal bupivacaine + Continuous popliteal nerve block with normal saline + Popliteal nerve block with exclusively unencapsulated bupivacaine + Adductor canal nerve block with exclusively unencapsulated bupivacaine + Continuous popliteal nerve block with unencapsulated bupivacainePacira BiosciencesApproved
44
DuloxetineEli LillyPhase 3
40
Pudexacianinium chlorideAstellas PharmaPhase 2
35
ISV-305Sun PharmaceuticalPhase 3
40
ISV-305Sun PharmaceuticalPhase 3
40
DE-108 + Levofloxacin 0.5%Santen PharmaceuticalPhase 3
40
SHR0410 Injection + SHR0410 Injection + PlaceboJiangsu Hengrui MedicinePhase 3
36
HR021618 + PlaceboJiangsu Hengrui MedicinePhase 2
35
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
40
Herombopag tablets + Herombopag placebo tabletsJiangsu Hengrui MedicinePhase 3
47
Omaveloxolone Ophthalmic Suspension 1.0% + Omaveloxolone Opthalmic Suspension 0.5% + PlaceboAbbViePhase 2
35
Placebo + ABT-719AbbViePhase 2
27
EsomeprazoleAstraZenecaApproved
43
Andexanet alfa + Usual CareAstraZenecaPhase 3
32
Sugammadex + Neostigmine + Glycopyrrolate + RocuroniumMerckApproved
50
Rocuronium + RocuroniumMerckApproved
43
SugammadexMerckApproved
43
etoricoxib 120 mgMerckApproved
43
Sugammadex + PlaceboMerckApproved
43